DionyMed Brands Inc. Announces Strategic Partnership with Nevada-Based Retailer Acres Cannabis

TORONTO–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a
multi-state vertically integrated cannabis brand and delivery platform,
today announced that it has signed a strategic partnership agreement
with Acres Cannabis (“Acres”), a vertically integrated cannabis retailer
based in Las Vegas, Nevada. The partnership grants DionyMed’s brands and
services immediate access to the highly coveted Nevada market, which
services more than 43 million tourists each year, and represents another
significant step in DionyMed’s national expansion plans.

Acres operates one of the largest cannabis cultivation and manufacturing
sites in the state of Nevada, as well as a 20,000 square foot dispensary
in the heart of Las Vegas. As part of the partnership agreement,
DionyMed’s infused products and edible brands, including its
award-winning Winberry Farms, will be manufactured in Acres’ facilities
and sold state-wide, providing DionyMed with a scalable platform to
penetrate the Nevada market.

Edward Fields, Chief Executive Officer of DionyMed commented,
“Expanding into one of the country’s largest cannabis markets requires
robust infrastructure and an established retail presence. Acres has all
the ingredients required to build and launch today’s largest cannabis
brands in Nevada. Entering Nevada has been a key growth objective for
the team at DYME and we are pleased to have reached this exciting
milestone.”

John Mueller, CEO of Acres Cannabis, added, “Acres is excited to partner
with a professional team like DionyMed with well-established brands that
will work exceptionally well for the 39
million annual tourists in Las Vegas
,” said John Mueller, CEO Acres
Cannabis.

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com
with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands and delivery
platform, supporting cultivators, manufacturers and award-winning brands
in the medical and adult-use cannabis markets. DionyMed sells branded
products in every category from flower to vape cartridges, concentrates
and edibles. DionyMed serves more than 700 dispensaries and completes
over 40,000 Direct-To-Consumer deliveries each month with its growing
portfolio of products and brands. Learn more at www.DionyMed.com and
follow @DYME_Inc on Twitter and LinkedIn.

Forward-Looking Information and Statements

This news release contains certain “forward-looking information”
within the meaning of applicable Canadian securities legislation and may
also contain statements that may constitute “forward-looking statements”
within the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Such forward-looking
information and forward-looking statements are not representative of
historical facts or information or current condition, but instead
represent only the Company’s beliefs regarding future events, plans or
objectives, many of which, by their nature, are inherently uncertain and
outside of the Company’s control. Generally, such forward-looking
information or forward-looking statements can be identified by the use
of forward-looking terminology such as “plans”, “expects” or “does not
expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”,
“intends”, “anticipates” or “does not anticipate”, or “believes”, or
variations of such words and phrases or may contain statements that
certain actions, events or results “may”, “could”, “would”, “might” or
“will be taken”, “will continue”, “will occur” or “will be achieved” and
include, without limitation, statements related to the implementation or
impact of certain regulations, the expansion of the Company’s online
platforms, enhancing the Company’s distribution reach and product
variety and changes to the Company’s revenue drivers.

By identifying such information and statements in this manner, the
Company is alerting the reader that such information and statements are
subject to known and unknown risks, uncertainties and other factors that
may cause the actual results, level of activity, performance or
achievements of the Company to be materially different from those
expressed or implied by such information and statements. In addition, in
connection with the forward-looking information and forward-looking
statements contained in this press release, the Company has made certain
assumptions.

Although the Company believes that the assumptions and factors used
in preparing, and the expectations contained in, the forward-looking
information and statements are reasonable, undue reliance should not be
placed on such information and statements, and no assurance or guarantee
can be given that such forward-looking information and statements will
prove to be accurate, as actual results and future events could differ
materially from those anticipated in such information and statements.
The forward-looking information and forward-looking statements contained
in this press release are made as of the date of this press release, and
the Company does not undertake to update any forward-looking information
and/or forward-looking statements that are contained or referenced
herein, except in accordance with applicable securities laws. All
subsequent written and oral forward- looking information and statements
attributable to the Company or persons acting on its behalf is expressly
qualified in its entirety by this notice.

Contacts

Edward Fields, CEO
edward@dionymed.com
408-656-4209

Peter Kampian, CFO
pkampian@dionymed.com
416-209-5982

Investor Contacts:
Phil Carlson / Erika Kay
KCSA
Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com
/ ekay@kcsa.com